Fuxi Zhen

464 total citations
15 papers, 252 citations indexed

About

Fuxi Zhen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fuxi Zhen has authored 15 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Fuxi Zhen's work include Esophageal Cancer Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (8 papers) and Esophageal and GI Pathology (4 papers). Fuxi Zhen is often cited by papers focused on Esophageal Cancer Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (8 papers) and Esophageal and GI Pathology (4 papers). Fuxi Zhen collaborates with scholars based in China and United States. Fuxi Zhen's co-authors include Tongfu Yu, Wei Wang, Renhua Guo, Shidai Jin, Jiaqi Yao, Kun Xu, Xinyin Liu, Xiyi Lu, Quan Zhu and Zhenzhen Gao and has published in prestigious journals such as Annals of Oncology, Medicine and BMC Cancer.

In The Last Decade

Fuxi Zhen

15 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuxi Zhen China 8 139 126 75 64 47 15 252
Yucai Wu China 9 165 1.2× 133 1.1× 83 1.1× 74 1.2× 41 0.9× 24 265
Masataka Shimonosono Japan 10 124 0.9× 104 0.8× 77 1.0× 67 1.0× 114 2.4× 29 286
Zhiqun Shang China 6 155 1.1× 119 0.9× 67 0.9× 60 0.9× 37 0.8× 8 282
Guangmao Yu China 10 156 1.1× 97 0.8× 100 1.3× 28 0.4× 44 0.9× 34 264
Shi‐Xun Lu China 12 109 0.8× 64 0.5× 96 1.3× 53 0.8× 120 2.6× 21 277
Ningyuan Wen China 7 71 0.5× 66 0.5× 63 0.8× 59 0.9× 62 1.3× 22 241
Shiming He China 6 138 1.0× 61 0.5× 74 1.0× 70 1.1× 71 1.5× 10 252
Tonći Šuštić Netherlands 7 192 1.4× 53 0.4× 54 0.7× 49 0.8× 72 1.5× 9 255
Shu-bo Tian China 8 122 0.9× 97 0.8× 138 1.8× 160 2.5× 56 1.2× 19 334
Maciej Oszczudłowski Poland 5 131 0.9× 84 0.7× 74 1.0× 156 2.4× 58 1.2× 14 291

Countries citing papers authored by Fuxi Zhen

Since Specialization
Citations

This map shows the geographic impact of Fuxi Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuxi Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuxi Zhen more than expected).

Fields of papers citing papers by Fuxi Zhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuxi Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuxi Zhen. The network helps show where Fuxi Zhen may publish in the future.

Co-authorship network of co-authors of Fuxi Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Fuxi Zhen. A scholar is included among the top collaborators of Fuxi Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuxi Zhen. Fuxi Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Gu, Yanhong, Lijun Xue, Fuxi Zhen, et al.. (2020). 175P A study of neoadjuvant sintilimab combined with triplet chemotherapy of lipo-paclitaxel, cisplatin, and S-1 for resectable esophageal squamous cell carcinoma (ESCC). Annals of Oncology. 31. S1307–S1308. 16 indexed citations
3.
Liu, Yiqian, Ann‐Kathrin Eisfeld, Fuxi Zhen, et al.. (2019). Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study. Frontiers in Oncology. 9. 550–550. 35 indexed citations
4.
Liu, Shu, Shengnan Ren, Xiaolin Ge, et al.. (2019). Concurrent liposomal paclitaxel and cisplatin chemotherapy improved outcomes for locally advanced esophageal squamous cell carcinoma treated with intensity-modulated radiotherapy. Annals of Translational Medicine. 7(14). 331–331. 7 indexed citations
5.
Liu, Xinyin, Xiyi Lu, Fuxi Zhen, et al.. (2019). LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC. Molecular Therapy — Nucleic Acids. 16. 155–161. 100 indexed citations
6.
Gao, Zhenzhen, et al.. (2019). Comprehensive Analysis of lncRNA–miRNA– mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer. Technology in Cancer Research & Treatment. 18. 1078120885–1078120885. 24 indexed citations
7.
8.
Gao, Zhenzhen, Xiaolin Ge, Jinyuan Liu, et al.. (2019). Comparison Between Size and Stage of Preoperative Tumor Defined by Preoperative Magnetic Resonance Imaging and Postoperative Specimens After Radical Resection of Esophageal Cancer. Technology in Cancer Research & Treatment. 18. 1078143911–1078143911. 5 indexed citations
9.
Liu, Jinyuan, Lei Xue, Fuxi Zhen, & Jinhua Luo. (2017). Efficacy and safety of chemoradiation therapy compared with chemotherapy for esophageal carcinoma. Medicine. 96(47). e8929–e8929. 3 indexed citations
10.
Zhang, Jingjing, Chunchun Zhi, Fuxi Zhen, et al.. (2017). iTRAQ‐Based Quantitative Proteomic Analyses of High Grade Esophageal Squamous Intraepithelial Neoplasia. PROTEOMICS - CLINICAL APPLICATIONS. 11(11-12). 8 indexed citations
11.
Wang, Jun, Wen Wei, Jing Xu, et al.. (2017). Clinical outcome of using gastric remnant or jejunum or colon conduit in surgery for esophageal carcinoma with previous gastrectomy. Journal of Surgical Oncology. 115(6). 729–737. 5 indexed citations
12.
13.
Zhen, Fuxi, et al.. (2016). [Study on the association of gastric conduit width and postoperative early delayed gastric emptying in middle-lower esophageal cancer patients undergoing Ivor-Lewis procedure].. PubMed. 19(9). 985–989. 2 indexed citations
14.
Ge, Xiaolin, Xi Yang, Xiaohu Lu, et al.. (2015). Long-term Clinical Outcome of Intensity-modulated Radiation Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Tumori Journal. 101(2). 168–173. 5 indexed citations
15.
Ge, Xiaolin, Fuxi Zhen, Baixia Yang, et al.. (2014). Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α. Journal of International Medical Research. 42(3). 628–640. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yucai Wu Breakdown of academic impact, for papers by Masataka Shimonosono Breakdown of academic impact, for papers by Zhiqun Shang Breakdown of academic impact, for papers by Guangmao Yu Breakdown of academic impact, for papers by Shi‐Xun Lu Breakdown of academic impact, for papers by Ningyuan Wen Breakdown of academic impact, for papers by Shiming He Breakdown of academic impact, for papers by Tonći Šuštić Breakdown of academic impact, for papers by Shu-bo Tian Breakdown of academic impact, for papers by Maciej Oszczudłowski
Rankless by CCL
2026